122 related articles for article (PubMed ID: 26001113)
1. ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26.
Perez Botero J; Oliveira JL; Chen D; Reichard KK; Viswanatha DS; Nguyen PL; Pruthi RK; Majerus J; Gada P; Gangat N; Tefferi A; Patnaik MM
Blood Cancer J; 2015 May; 5(5):e315. PubMed ID: 26001113
[No Abstract] [Full Text] [Related]
2. 5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia.
Marconi C; Canobbio I; Bozzi V; Pippucci T; Simonetti G; Melazzini F; Angori S; Martinelli G; Saglio G; Torti M; Pastan I; Seri M; Pecci A
J Hematol Oncol; 2017 Jan; 10(1):18. PubMed ID: 28100250
[TBL] [Abstract][Full Text] [Related]
3. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
Elliott MA; Pardanani A; Hanson CA; Lasho TL; Finke CM; Belachew AA; Tefferi A
Am J Hematol; 2015 Jul; 90(7):653-6. PubMed ID: 25850813
[TBL] [Abstract][Full Text] [Related]
4. Inherited Thrombocytopenia Caused by Germline
Kewan T; Noss R; Godley LA; Rogers HJ; Carraway HE
J Investig Med High Impact Case Rep; 2020; 8():2324709620938941. PubMed ID: 32618208
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.
Bluteau D; Balduini A; Balayn N; Currao M; Nurden P; Deswarte C; Leverger G; Noris P; Perrotta S; Solary E; Vainchenker W; Debili N; Favier R; Raslova H
J Clin Invest; 2014 Feb; 124(2):580-91. PubMed ID: 24430186
[TBL] [Abstract][Full Text] [Related]
6. Inherited thrombocytopenia caused by ANKRD26 mutations misdiagnosed and treated as myelodysplastic syndrome: report on two cases.
Zaninetti C; Santini V; Tiniakou M; Barozzi S; Savoia A; Pecci A
J Thromb Haemost; 2017 Dec; 15(12):2388-2392. PubMed ID: 28976612
[TBL] [Abstract][Full Text] [Related]
7. Mutated
Valencia-Martinez A; Sanna A; Masala E; Contini E; Brogi A; Gozzini A; Santini V
Haematologica; 2017 Sep; 102(9):e332-e335. PubMed ID: 28522578
[No Abstract] [Full Text] [Related]
8. Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes.
Patnaik MM; Padron E; LaBorde RR; Lasho TL; Finke CM; Hanson CA; Hodnefield JM; Knudson RA; Ketterling RP; Al-kali A; Pardanani A; Ali NA; Komrokji RS; Tefferi A
Leukemia; 2013 Jul; 27(7):1504-10. PubMed ID: 23531518
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2.
Pippucci T; Savoia A; Perrotta S; Pujol-Moix N; Noris P; Castegnaro G; Pecci A; Gnan C; Punzo F; Marconi C; Gherardi S; Loffredo G; De Rocco D; Scianguetta S; Barozzi S; Magini P; Bozzi V; Dezzani L; Di Stazio M; Ferraro M; Perini G; Seri M; Balduini CL
Am J Hum Genet; 2011 Jan; 88(1):115-20. PubMed ID: 21211618
[TBL] [Abstract][Full Text] [Related]
10. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
Gelsi-Boyer V; Trouplin V; Roquain J; Adélaïde J; Carbuccia N; Esterni B; Finetti P; Murati A; Arnoulet C; Zerazhi H; Fezoui H; Tadrist Z; Nezri M; Chaffanet M; Mozziconacci MJ; Vey N; Birnbaum D
Br J Haematol; 2010 Nov; 151(4):365-75. PubMed ID: 20880116
[TBL] [Abstract][Full Text] [Related]
11. EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental.
Patnaik MM; Vallapureddy R; Lasho TL; Hoversten KP; Finke CM; Ketterling R; Hanson C; Gangat N; Tefferi A
Blood Cancer J; 2018 Jan; 8(1):12. PubMed ID: 29358618
[No Abstract] [Full Text] [Related]
12. [Mild bleeding diathesis in a 62-year-old woman with hereditary thrombocytopenia].
Ventz R; Hundemer M; Witzens-Harig M; Lehmann B; Felbor U; Najm J
Internist (Berl); 2013 Jun; 54(6):765-8. PubMed ID: 23677566
[TBL] [Abstract][Full Text] [Related]
13. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Gelsi-Boyer V; Trouplin V; Adélaïde J; Bonansea J; Cervera N; Carbuccia N; Lagarde A; Prebet T; Nezri M; Sainty D; Olschwang S; Xerri L; Chaffanet M; Mozziconacci MJ; Vey N; Birnbaum D
Br J Haematol; 2009 Jun; 145(6):788-800. PubMed ID: 19388938
[TBL] [Abstract][Full Text] [Related]
14. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.
Patnaik MM; Itzykson R; Lasho TL; Kosmider O; Finke CM; Hanson CA; Knudson RA; Ketterling RP; Tefferi A; Solary E
Leukemia; 2014 Nov; 28(11):2206-12. PubMed ID: 24695057
[TBL] [Abstract][Full Text] [Related]
15. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
Boultwood J; Perry J; Pellagatti A; Fernandez-Mercado M; Fernandez-Santamaria C; Calasanz MJ; Larrayoz MJ; Garcia-Delgado M; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Hellström-Lindberg E; Cazzola M; Wainscoat JS
Leukemia; 2010 May; 24(5):1062-5. PubMed ID: 20182461
[No Abstract] [Full Text] [Related]
16. Collaborating constitutive and somatic genetic events in myeloid malignancies: ASXL1 mutations in patients with germline GATA2 mutations.
Micol JB; Abdel-Wahab O
Haematologica; 2014 Feb; 99(2):201-3. PubMed ID: 24497555
[No Abstract] [Full Text] [Related]
17. CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes.
Bezerra ED; Lasho TL; Finke CM; Saliba AN; Elliott MA; Pardanani AD; Gangat N; Mangaonkar AA; Ketterling RP; Tefferi A; Solary E; Patnaik MM
Blood Cancer J; 2021 Mar; 11(3):54. PubMed ID: 33707412
[No Abstract] [Full Text] [Related]
18. A familial deletion of 10p12.1 associated with thrombocytopenia.
Manohar S; Gofin Y; Streff H; Vossaert L; Camacho P; Murali CN
Am J Med Genet A; 2024 Jan; 194(1):77-81. PubMed ID: 37746810
[TBL] [Abstract][Full Text] [Related]
19. ETV6-related thrombocytopenia and leukemia predisposition.
Di Paola J; Porter CC
Blood; 2019 Aug; 134(8):663-667. PubMed ID: 31248877
[TBL] [Abstract][Full Text] [Related]
20. Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Itzykson R; Kosmider O; Renneville A; Gelsi-Boyer V; Meggendorfer M; Morabito M; Berthon C; Adès L; Fenaux P; Beyne-Rauzy O; Vey N; Braun T; Haferlach T; Dreyfus F; Cross NC; Preudhomme C; Bernard OA; Fontenay M; Vainchenker W; Schnittger S; Birnbaum D; Droin N; Solary E
J Clin Oncol; 2013 Jul; 31(19):2428-36. PubMed ID: 23690417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
